Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Alkermes plc - Ordinary Shares
(NQ:
ALKS
)
34.91
+0.19 (+0.55%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 11, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,352,682
Open
34.89
Bid (Size)
30.98 (400)
Ask (Size)
36.00 (400)
Prev. Close
34.72
Today's Range
33.91 - 35.15
52wk Range
25.16 - 36.45
Shares Outstanding
166,121,384
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Alkermes to Report Fourth Quarter and Year-End Financial Results on Feb. 25, 2026
Today 16:00 EST
From
Alkermes plc
Via
Business Wire
Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
January 06, 2026
From
Alkermes plc
Via
Business Wire
Performance
YTD
+23.5%
+23.5%
1 Month
+17.9%
+17.9%
3 Month
+3.3%
+3.3%
6 Month
+27.3%
+27.3%
1 Year
+11.8%
+11.8%
More News
Read More
Alkermes to Present at the 44th Annual J.P. Morgan Healthcare Conference
December 30, 2025
From
Alkermes plc
Via
Business Wire
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge
↗
November 19, 2025
Via
Stocktwits
Earnings Scheduled For October 28, 2025
↗
October 28, 2025
Via
Benzinga
Preview: Alkermes's Earnings
↗
October 27, 2025
Via
Benzinga
Alkermes to Participate in Two Upcoming Investor Conferences
November 25, 2025
From
Alkermes plc
Via
Business Wire
Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal
↗
November 14, 2025
Via
Benzinga
Avadel Surges 20% On Lundbeck's Surprise Alkermes-Topping Bid
↗
November 14, 2025
Via
Investor's Business Daily
Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes
↗
November 14, 2025
Via
Stocktwits
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
November 13, 2025
Via
Benzinga
Alkermes Eyes Global Phase 3 Trial After Encouraging Data From Sleep Disorder Study
↗
November 12, 2025
Via
Benzinga
This Alkermes Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday
↗
November 11, 2025
Via
Benzinga
ALKERMES PLC (NASDAQ:ALKS) Q3 2025 Earnings Beat Estimates and Drive Stock Surge
↗
October 28, 2025
Via
Chartmill
Topics
Earnings
Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups
↗
October 24, 2025
Via
Benzinga
Topics
Government
Breaking Down Alkermes: 8 Analysts Share Their Views
↗
October 23, 2025
Via
Benzinga
Alkermes Strikes $2.1 Billion Avadel Deal, Gains Access To Narcolepsy Drug Lumryz
↗
October 22, 2025
Via
Benzinga
Avadel Pharmaceuticals Soars as Alkermes Announces $2.1 Billion Acquisition
October 22, 2025
Via
MarketMinute
Topics
Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Avadel Pharmaceuticals plc (Nasdaq – AVDL), Middlefield Banc Corp. (Nasdaq – MBCN), Heidrick & Struggles International, Inc. (Nasdaq - HSII), Comerica Incorporated
October 22, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
Avadel Jumps On $2.1 Billion Takeover Deal. But Buyer, Alkermes, Dives.
↗
October 22, 2025
Via
Investor's Business Daily
Avadel Stock Rises After Acquisition Offer By Alkermes
↗
October 22, 2025
Via
Stocktwits
9 Analysts Assess Alkermes: What You Need To Know
↗
September 26, 2025
Via
Benzinga
This Ciena Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
↗
September 26, 2025
Via
Benzinga
Deep Dive Into Alkermes Stock: Analyst Perspectives (7 Ratings)
↗
September 03, 2025
Via
Benzinga
Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday
↗
September 03, 2025
Via
Benzinga
Frequently Asked Questions
Is Alkermes plc - Ordinary Shares publicly traded?
Yes, Alkermes plc - Ordinary Shares is publicly traded.
What exchange does Alkermes plc - Ordinary Shares trade on?
Alkermes plc - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Alkermes plc - Ordinary Shares?
The ticker symbol for Alkermes plc - Ordinary Shares is ALKS on the Nasdaq Stock Market
What is the current price of Alkermes plc - Ordinary Shares?
The current price of Alkermes plc - Ordinary Shares is 34.91
When was Alkermes plc - Ordinary Shares last traded?
The last trade of Alkermes plc - Ordinary Shares was at 02/11/26 04:00 PM ET
What is the market capitalization of Alkermes plc - Ordinary Shares?
The market capitalization of Alkermes plc - Ordinary Shares is 5.80B
How many shares of Alkermes plc - Ordinary Shares are outstanding?
Alkermes plc - Ordinary Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
